Plus Therapeutics, Inc. (PSTV)

Plus Therapeutics Revenue

In the year 2023, Plus Therapeutics had annual revenue of $4.91M with 2,093.30% growth. Revenue in the quarter ending December 31, 2023 was $1.31M with 769.54% year-over-year growth.

• Revenue (ttm): $4.91M
• Revenue Growth: +2,093.30%
• P/S Ratio: 1.49
• Revenue / Employee: $245,650
• Employees: 20
• Market Cap: 7.35M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.91M	4.69M	2,093.30%
Dec 31, 2022	224.00K	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	303.00K	-6.70M	-95.67%
Dec 31, 2019	7.00M	4.02M	134.60%
Dec 31, 2018	2.98M	-3.43M	-53.47%
Dec 31, 2017	6.41M	-4.97M	-43.66%
Dec 31, 2016	11.38M	-279.00K	-2.39%
Dec 31, 2015	11.66M	4.06M	53.45%
Dec 31, 2014	7.60M	-4.60M	-37.70%
Dec 31, 2013	12.20M	-2.31M	-15.90%
Dec 31, 2012	14.50M	4.51M	45.07%
Dec 31, 2011	10.00M	-631.00K	-5.94%
Dec 31, 2010	10.63M	-4.10M	-27.85%
Dec 31, 2009	14.73M	7.88M	114.94%
Dec 31, 2008	6.85M	804.00K	13.29%
Dec 31, 2007	6.05M	-1.88M	-23.69%
Dec 31, 2006	7.93M	1.92M	32.01%
Dec 31, 2005	6.01M	-813.00K	-11.92%
Dec 31, 2004	6.82M	-7.27M	-51.60%
Dec 31, 2003	14.09M	4.92M	53.70%
Dec 31, 2002	9.17M	3.52M	62.29%
Dec 31, 2001	5.65M	-603.00K	-9.65%
Dec 31, 2000	6.25M	4.74M	313.15%
Dec 31, 1999	1.51M	-	-
Dec 31, 1998	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.